Clinical Trials Browser

Phase 2/3 × Terminated × Bevacizumab × Clear all

Vipoma, Glucagonoma, Insulinoma, Adenoma, Islet Cell, Lung Neoplasms, Neoplasms, Somatostatinoma, Gastrinoma, Carcinoma, Islet Cell, Neuroendocrine Tumors

NCT02414165 2020-02-07

Toca5

Phase 2/3 Terminated

403 enrolled

CNS

Astrocytoma, Glioblastoma, Recurrence

NCT01383148 2017-01-05

TIME

Phase 2/3 Terminated

222 enrolled

Thoracic

Carcinoma, Non-Small-Cell Lung

Clinical Trials

Combination Chemotherapy and Bevacizumab in Treating Patients With Advanced Neuroendocrine Tumors

Toca5

TIME